N/A N=45 Basic Science

Clinical Experiment of Helicobacter Pylori Transmission

Infection · Achlorhydria

Bottom Line

View on ClinicalTrials.gov: NCT00550368 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2016

Primary outcome: Primary: Development of Diarrhea — 5; 6 participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Biological intervention: Enteropathogenic E. coli (Biological)
Age: Adult · 35+ yrs
Sex: All
Sponsor: Stanford University
Primary completion: Apr 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Development of Diarrhea	5; 6	—
SECONDARY Intensity of Gastrointestinal Symptoms	3; 3	—

Summary

The study proposes to test whether chronic infection with Helicobacter pylori protects individuals from symptomatic infection with enteropathogenic E. coli. The study will also evaluate the effect of gastric acidity in this relationship.

Eligibility Criteria

Inclusion Criteria:Healthy Exclusion Criteria:prior gastrointestinal disease prior treatment of H. pylori infection immune suppression or deficiency history of cancer, diabetes, or other co-morbidity

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00550368). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.